This article is taken from the monthly Sciences et Avenir – La Recherche ndeg931, dated September 2024.
Nobody has forgotten the Mediator affair and the repeated scandals related to appetite suppressants have left their mark. Could GLP-1 be next? "We have about twenty years of experience with this class of drugs. However, the serious adverse effects of appetite suppressants have appeared, for the most part, within fifteen yearsJean-Paul Thissen, an endocrinologist says: "It's a fact that the GLP-1 receptor agonists have side effects." However, like any medication, GLP-1 receptor agonists have side effects.